Key result
Percutaneous coronary intervention for bifurcation lesions was associated with significantly higher inpatient mortality compared to non-bifurcation lesions (adjusted OR 1.68, 95% CI 1.49-1.88, p<0.001).
Why the study?
Percutaneous coronary intervention in bifurcation lesions is associated with higher complexity and adverse outcomes, prompting an evaluation of inpatient outcomes in these patients.
Does percutaneous coronary intervention of bifurcation lesions increase mortality and complications compared to non-bifurcation lesions in adult patients?
Observational (n=9,795,154)
Yes
Does percutaneous coronary intervention of bifurcation lesions increase mortality and complications compared to non-bifurcation lesions in adult patients?
Odds Ratio: 1.68 (95% CI 1.49–1.88)
Absolute Event Rate: 3.79% vs 2.56%
p-value: p=<0.001
Percutaneous coronary intervention of non-CTO bifurcation lesions is associated with significantly higher inpatient mortality and procedural complications compared to non-bifurcation PCI.
Bifurcation PCI was associated with higher inpatient mortality and complications; leaves open whether optimized techniques reduce risk in prospective trials.
Background Percutaneous coronary intervention (PCI) in patients with bifurcation lesions is associated with higher complexity and adverse outcomes. The goal of this study was to evaluate the inpatient outcomes of patients with PCI of bifurcation lesions. Methods The National Inpatient Sample (NIS) database, years 2016-2020, was studied using ICD 10 codes. Patients with bifurcation lesion PCI were compared to other PCIs excluding chronic total occlusions (CTO). We evaluated post-procedural inpatient mortality and complications. Results PCI in patients with a bifurcation lesion was associated with higher mortality and post-procedural complications. A weighted total of 9,795,154 patients underwent PCI, with 43,480 having a bifurcation lesion. The bifurcation group had a 3.79% mortality rate vs 2.56%. (OR, 1.50; CI:1.34–1.68; p<0.001). After adjusting for age, sex, race, diabetes mellitus, and chronic kidney disease, bifurcation lesion PCI remained significantly associated with higher mortality (OR, 1.68; 95% CI, 1.49– 1.88; p<0.001). Furthermore, bifurcation PCI was associated with higher rates of myocardial infarction (OR, 2.26; 95% CI, 1.68 – 3.06; p<0.001), coronary perforation (OR, 7.97; 95% CI, 6.25-10.17; p<0.001), tamponade (OR, 3.46; 95% CI, 2.49-4.82, p<0.001), and procedural bleeding (OR, 5.71; 95% CI, 4.85-6.71, p<0.001). All post-procedural complications were more than 4 times more likely in patients with bifurcation than in those without (OR, 4.33; 95% CI, 3.83-4.88; p<0.001). Conclusion Using a large national inpatient database, PCI performed in patients with a Non-CTO bifurcation lesions were associated with significantly higher mortality and post-procedural complications.
No takes yet. Share an insight, caveat, or question.
Nathan et al. (2023) conducted an observational in Coronary artery disease requiring percutaneous coronary intervention (n=9,795,154). PCI of bifurcation lesions vs. PCI of non-bifurcation lesions was evaluated on Inpatient mortality (OR 1.68, 95% CI 1.49-1.88, p=<0.001). Percutaneous coronary intervention for bifurcation lesions was associated with significantly higher inpatient mortality compared to non-bifurcation lesions (adjusted OR 1.68, 95% CI 1.49-1.88, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: